150 related articles for article (PubMed ID: 27026062)
1. Involvement of aspartoacylase in tremor expression in rats.
Nishitani A; Tanaka M; Shimizu S; Kunisawa N; Yokoe M; Yoshida Y; Suzuki T; Sakuma T; Yamamoto T; Kuwamura M; Takenaka S; Ohno Y; Kuramoto T
Exp Anim; 2016 Jul; 65(3):293-301. PubMed ID: 27026062
[TBL] [Abstract][Full Text] [Related]
2. Involvement of NMDA receptors in tremor expression in Aspa/Hcn1 double-knockout rats.
Nishitani A; Nagayoshi H; Takenaka S; Asano M; Shimizu S; Ohno Y; Kuramoto T
Exp Anim; 2020 Nov; 69(4):388-394. PubMed ID: 32507787
[TBL] [Abstract][Full Text] [Related]
3. Hcn1 is a tremorgenic genetic component in a rat model of essential tremor.
Ohno Y; Shimizu S; Tatara A; Imaoku T; Ishii T; Sasa M; Serikawa T; Kuramoto T
PLoS One; 2015; 10(5):e0123529. PubMed ID: 25970616
[TBL] [Abstract][Full Text] [Related]
4. Effects of AAV-2-mediated aspartoacylase gene transfer in the tremor rat model of Canavan disease.
McPhee SW; Francis J; Janson CG; Serikawa T; Hyland K; Ong EO; Raghavan SS; Freese A; Leone P
Brain Res Mol Brain Res; 2005 Apr; 135(1-2):112-21. PubMed ID: 15857674
[TBL] [Abstract][Full Text] [Related]
5. Nur7 is a nonsense mutation in the mouse aspartoacylase gene that causes spongy degeneration of the CNS.
Traka M; Wollmann RL; Cerda SR; Dugas J; Barres BA; Popko B
J Neurosci; 2008 Nov; 28(45):11537-49. PubMed ID: 18987190
[TBL] [Abstract][Full Text] [Related]
6. Restoration of aspartoacylase activity in CNS neurons does not ameliorate motor deficits and demyelination in a model of Canavan disease.
Klugmann M; Leichtlein CB; Symes CW; Serikawa T; Young D; During MJ
Mol Ther; 2005 May; 11(5):745-53. PubMed ID: 15851013
[TBL] [Abstract][Full Text] [Related]
7. Accumulation of N-acetyl-L-aspartate in the brain of the tremor rat, a mutant exhibiting absence-like seizure and spongiform degeneration in the central nervous system.
Kitada K; Akimitsu T; Shigematsu Y; Kondo A; Maihara T; Yokoi N; Kuramoto T; Sasa M; Serikawa T
J Neurochem; 2000 Jun; 74(6):2512-9. PubMed ID: 10820213
[TBL] [Abstract][Full Text] [Related]
8. Adenoviral gene transfer of aspartoacylase into the tremor rat, a genetic model of epilepsy, as a trial of gene therapy for inherited epileptic disorder.
Seki T; Matsubayashi H; Amano T; Kitada K; Serikawa T; Sakai N; Sasa M
Neurosci Lett; 2002 Aug; 328(3):249-52. PubMed ID: 12147318
[TBL] [Abstract][Full Text] [Related]
9. Extensive aspartoacylase expression in the rat central nervous system.
Moffett JR; Arun P; Ariyannur PS; Garbern JY; Jacobowitz DM; Namboodiri AM
Glia; 2011 Oct; 59(10):1414-34. PubMed ID: 21598311
[TBL] [Abstract][Full Text] [Related]
10. N-Acetylaspartate Synthase Deficiency Corrects the Myelin Phenotype in a Canavan Disease Mouse Model But Does Not Affect Survival Time.
Maier H; Wang-Eckhardt L; Hartmann D; Gieselmann V; Eckhardt M
J Neurosci; 2015 Oct; 35(43):14501-16. PubMed ID: 26511242
[TBL] [Abstract][Full Text] [Related]
11. Myelin lesion in the aspartoacylase (Aspa) knockout rat, an animal model for Canavan disease.
Takeda S; Hoshiai R; Tanaka M; Izawa T; Yamate J; Kuramoto T; Kuwamura M
Exp Anim; 2024 Mar; ():. PubMed ID: 38538326
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical localization of aspartoacylase in the rat central nervous system.
Madhavarao CN; Moffett JR; Moore RA; Viola RE; Namboodiri MA; Jacobowitz DM
J Comp Neurol; 2004 May; 472(3):318-29. PubMed ID: 15065127
[TBL] [Abstract][Full Text] [Related]
13. Adeno-associated virus-mediated aspartoacylase gene transfer to the brain of knockout mouse for canavan disease.
Matalon R; Surendran S; Rady PL; Quast MJ; Campbell GA; Matalon KM; Tyring SK; Wei J; Peden CS; Ezell EL; Muzyczka N; Mandel RJ
Mol Ther; 2003 May; 7(5 Pt 1):580-7. PubMed ID: 12718900
[TBL] [Abstract][Full Text] [Related]
14. Canavan disease: genomic organization and localization of human ASPA to 17p13-ter and conservation of the ASPA gene during evolution.
Kaul R; Balamurugan K; Gao GP; Matalon R
Genomics; 1994 May; 21(2):364-70. PubMed ID: 8088831
[TBL] [Abstract][Full Text] [Related]
15. Absence-like and tonic seizures in aspartoacylase/attractin double-mutant mice.
Gohma H; Kuramoto T; Matalon R; Surendran S; Tyring S; Kitada K; Sasa M; Serikawa T
Exp Anim; 2007 Apr; 56(2):161-5. PubMed ID: 17460362
[TBL] [Abstract][Full Text] [Related]
16. Muscle weakness and impaired motor coordination in hyperpolarization-activated cyclic nucleotide-gated potassium channel 1-deficient rats.
Nishitani A; Yoshihara T; Tanaka M; Kuwamura M; Asano M; Tsubota Y; Kuramoto T
Exp Anim; 2020 Jan; 69(1):11-17. PubMed ID: 31292305
[TBL] [Abstract][Full Text] [Related]
17. Suppressing N-Acetyl-l-Aspartate Synthesis Prevents Loss of Neurons in a Murine Model of Canavan Leukodystrophy.
Sohn J; Bannerman P; Guo F; Burns T; Miers L; Croteau C; Singhal NK; McDonough JA; Pleasure D
J Neurosci; 2017 Jan; 37(2):413-421. PubMed ID: 28077719
[TBL] [Abstract][Full Text] [Related]
18. Aspartoacylase is a regulated nuclear-cytoplasmic enzyme.
Hershfield JR; Madhavarao CN; Moffett JR; Benjamins JA; Garbern JY; Namboodiri A
FASEB J; 2006 Oct; 20(12):2139-41. PubMed ID: 16935940
[TBL] [Abstract][Full Text] [Related]
19. Loss of HCN1 enhances disease progression in mouse models of CNG channel-linked retinitis pigmentosa and achromatopsia.
Schön C; Asteriti S; Koch S; Sothilingam V; Garcia Garrido M; Tanimoto N; Herms J; Seeliger MW; Cangiano L; Biel M; Michalakis S
Hum Mol Genet; 2016 Mar; 25(6):1165-75. PubMed ID: 26740549
[TBL] [Abstract][Full Text] [Related]
20. Metabolic acetate therapy improves phenotype in the tremor rat model of Canavan disease.
Arun P; Madhavarao CN; Moffett JR; Hamilton K; Grunberg NE; Ariyannur PS; Gahl WA; Anikster Y; Mog S; Hallows WC; Denu JM; Namboodiri AM
J Inherit Metab Dis; 2010 Jun; 33(3):195-210. PubMed ID: 20464498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
